OptimizeRx (OPRX) Other Operating Expenses (2010 - 2026)

OptimizeRx (OPRX) has 17 years of Other Operating Expenses data on file, last reported at $12.5 million in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses fell 13.49% year-over-year to $12.5 million; the trailing twelve-month figure through Mar 2026 stood at $30.2 million (down 28.96% YoY), and the FY2025 full-year result was $11.7 million, down 49.94% from the prior year.
• Other Operating Expenses retreated to $12.5 million in Q1 2026, from $15.5 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $28.7 million in Q4 2023 to a low of $464000.0 in Q1 2023.
• A 5-year average of $7.2 million and a median of $1.1 million in 2025 frame the typical range for Other Operating Expenses.
• Across the five-year window, Other Operating Expenses sank 90.83% in 2022 and surged 1738.12% in 2024, its largest moves.
• Tracing OPRX's Other Operating Expenses over 5 years: stood at $16.2 million in 2022, then surged by 77.41% to $28.7 million in 2023, then sank by 36.03% to $18.4 million in 2024, then decreased by 15.54% to $15.5 million in 2025, then fell by 19.3% to $12.5 million in 2026.
• Business Quant data shows OPRX's Other Operating Expenses at $12.5 million in Q1 2026, $15.5 million in Q4 2025, and $1.1 million in Q3 2025.